Publications by authors named "Michael Savin"

Claim this Profile
M
Mechanical Thrombectomy for High-Risk Pulmonary Embolism: Insights From the US Cohort of the FLASH Registry.
James M Horowitz, Wissam A Jaber, Brian Stegman, Michael Rosenberg, Christina Fanola, Michael Savin

J Soc Cardiovasc Angiogr Interv· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute outcomes for the full US cohort of the FLASH mechanical thrombectomy registry in pulmonary embolism.
Catalin Toma, Wissam A Jaber, Mitchell D Weinberg, Matthew C Bunte, Sameer Khandhar, Michael Savin

EuroIntervention· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Percutaneous mechanical thrombectomy in a real-world pulmonary embolism population: Interim results of the FLASH registry.
Catalin Toma, Matthew C Bunte, Kenneth H Cho, Wissam A Jaber, Jeffrey Chambers, Michael Savin

Catheter Cardiovasc Interv· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanical Thrombectomy in Pulmonary Embolism Associated with COVID-19: A "Clotography" Gallery.
Dinu V Balanescu, Herman S Kado, Amy Mertens, Rajat Chand, Michael Savin

Vasc Endovascular Surg· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Ado-trastuzumab for the treatment of metastatic HER2-positive breast cancer in patients previously treated with Pertuzumab.
Luai S Al Rabadi, Madeline M Cook, Andy J Kaempf, Megan M Saraceni, Michael A Savin

BMC Cancer· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Everolimus Plus Exemestane Treatment in Patients with Metastatic Hormone Receptor-Positive Breast Cancer Previously Treated with CDK4/6 Inhibitor Therapy.
Madeline M Cook, Luai Al Rabadi, Andy J Kaempf, Megan M Saraceni, Michael A Savin

Oncologist· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-reported and objectively measured physical function in older breast cancer survivors and cancer-free controls.
Kerri M Winters-Stone, Mary E Medysky, Michael A Savin

J Geriatr Oncol· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum to updated survival outcomes and analysis of long-term survivors from the MORE study on safety and efficacy of radioembolization in patients with unresectable colorectal cancer liver metastases.
Andrew Kennedy, Michael Cohn, Douglas M Coldwell, Alain Drooz, Eduardo Ehrenwald, Michael A Savin

J Gastrointest Oncol· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patterns of Biomarker Testing Rates and Appropriate Use of Targeted Therapy in the First-Line, Metastatic Non-Small Cell Lung Cancer Treatment Setting.
Casey Mason, Peter G Ellis, Kathy Lokay, Amanda Barry, Natalie Dickson, Michael Savin

J Clin Pathw· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Updated survival outcomes and analysis of long-term survivors from the MORE study on safety and efficacy of radioembolization in patients with unresectable colorectal cancer liver metastases.
Andrew Kennedy, Michael Cohn, Douglas M Coldwell, Alain Drooz, Eduardo Ehrenwald, Michael A Savin

J Gastrointest Oncol· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline hemoglobin and liver function predict tolerability and overall survival of patients receiving radioembolization for chemotherapy-refractory metastatic colorectal cancer.
Andrew S Kennedy, David Ball, Steven J Cohen, Michael Cohn, Douglas M Coldwell, Michael Savin

J Gastrointest Oncol· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatopulmonary Shunting: A Prognostic Indicator of Survival in Patients with Metastatic Colorectal Adenocarcinoma Treated with Y Radioembolization.
Kazim H Narsinh, Mark Van Buskirk, Andrew S Kennedy, Mohammed Suhail, Naif Alsaikhan, Michael A Savin

Radiology· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Efficacy of Radioembolization in Elderly (≥ 70 Years) and Younger Patients With Unresectable Liver-Dominant Colorectal Cancer.
Andrew S Kennedy, David S Ball, Steven J Cohen, Michael Cohn, Douglas Coldwell, Michael A Savin

Clin Colorectal Cancer· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Y
Yttrium-90 Infusion: Incidence and Outcome of Delivery System Occlusions during 885 Deliveries.
Michael A Savin, Monzer Chehab, Janice M Campbell, Jeffrey H Savin, Charles Cash

J Vasc Interv Radiol· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatic imaging response to radioembolization with yttrium-90-labeled resin microspheres for tumor progression during systemic chemotherapy in patients with colorectal liver metastases.
Andrew S Kennedy, David S Ball, Steven J Cohen, Michael Cohn, Douglas M Coldwell, Michael A Savin

J Gastrointest Oncol· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicenter evaluation of the safety and efficacy of radioembolization in patients with unresectable colorectal liver metastases selected as candidates for (90)Y resin microspheres.
Andrew S Kennedy, David Ball, Steven J Cohen, Michael Cohn, Douglas M Coldwell, Michael A Savin

J Gastrointest Oncol· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative measurement of HER2 expression in breast cancers: comparison with 'real-world' routine HER2 testing in a multicenter Collaborative Biomarker Study and correlation with overall survival.
Denise A Yardley, Peter A Kaufman, Weidong Huang, Lea Krekow, Michael Savin

Breast Cancer Res· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Y
Yttrium-90 radioembolization of malignant tumors of the liver: gallbladder effects.
Alan A Sag, Michael A Savin, Nirish R Lal, Rajul R Mehta

AJR Am J Roentgenol· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of saline flush injection rate in displacement of CT-injectable peripherally inserted central catheter tip during power injection of contrast material.
Peter Morden, Farnoosh Sokhandon, Laura Miller, Michael Savin, Matthias Kirsch

AJR Am J Roentgenol· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevention of chemotherapy-induced neutropenia with pegfilgrastim: pharmacokinetics and patient outcomes.
Bing-Bing Yang, Michael A Savin, Michael Green

Chemotherapy· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II study of eribulin mesylate (E7389) in patients with advanced, previously treated non-small-cell lung cancer.
Alexander I Spira, Nicholas O Iannotti, Michael A Savin, Marcus Neubauer, Nashat Y Gabrail

Clin Lung Cancer· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography predicts extrahepatic metastatic potential of colorectal metastasis: a practical guide for yttrium-90 microsphere liver-directed therapy.
Ching-Yee Oliver Wong, Vanessa L Gates, Bingfeng Tang, Janice Campbell, Feng Qing, Michael Savin

Cancer Biother Radiopharm· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiation microsphere-induced GI ulcers after selective internal radiation therapy for hepatic tumors: an underrecognized clinical entity.
Amulya Konda, Michael A Savin, Mitchell S Cappell, Michael C Duffy

Gastrointest Endosc· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Y
Y-90 microsphere therapy: prevention of adverse events.
Cheryl C Schultz, Janice Campbell, Donovan Bakalyar, Michele Beauvais, Wenzheng Feng, Michael Savin

Cancer Biother Radiopharm· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Docetaxel With Cyclophosphamide Is Associated With an Overall Survival Benefit Compared With Doxorubicin and Cyclophosphamide: 7-Year Follow-Up of US Oncology Research Trial 9735.
Stephen Jones, Frankie Ann Holmes, Joyce O'Shaughnessy, Joanne L Blum, Svetislava J Vukelja, Michael A Savin

J Clin Oncol· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis